Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Living donor liver transplantation to patients with hepatitis C virus cirrhosis.

Literature DB >> 16874855

Living donor liver transplantation to patients with hepatitis C virus cirrhosis.

Abstract

Living donor liver transplantation (LDLT) is an alternative therapeutic option for patients with end-stage hepatitis C virus (HCV) cirrhosis because of the cadaveric organ shortage. HCV infection is now a leading indication for LDLT among adults worldwide, and there is a worse prognosis with HCV recurrence. The antivirus strategy after transplantation, however, is currently under debate. Recent updates on the clinical and therapeutic aspects of living donor liver transplantation for HCV are discussed in the present review.

Entities: Disease Species

Mesh：

Substances：

Year: 2006 PMID： 16874855 PMCID： PMC4125630 DOI： 10.3748/wjg.v12.i28.4461

Source DB: PubMed Journal: World J Gastroenterol ISSN： 1007-9327 Impact factor: 5.742

40 in total

1. Is severe recurrent hepatitis C more common after adult living donor liver transplantation?

Authors: Mark W Russo; Roshan Shrestha
Journal: Hepatology Date: 2004-09 Impact factor: 17.425

2. Diagnosis, management, and treatment of hepatitis C.

Authors: Doris B Strader; Teresa Wright; David L Thomas; Leonard B Seeff
Journal: Hepatology Date: 2004-04 Impact factor: 17.425

3. Successful liver transplantation from a living donor to her son.

Authors: R W Strong; S V Lynch; T H Ong; H Matsunami; Y Koido; G A Balderson
Journal: N Engl J Med Date: 1990-05-24 Impact factor: 91.245

4. Successful living-related partial liver transplantation to an adult patient.

Authors: Y Hashikura; M Makuuchi; S Kawasaki; H Matsunami; T Ikegami; Y Nakazawa; K Kiyosawa; T Ichida
Journal: Lancet Date: 1994-05-14 Impact factor: 79.321

5. The influence of HLA donor-recipient compatibility on the recurrence of HBV and HCV hepatitis after liver transplantation.

Authors: R Mañez; R Mateo; J Tabasco; S Kusne; T E Starzl; R J Duquesnoy
Journal: Transplantation Date: 1995-02-27 Impact factor: 4.939

6. Impact of hepatitis C viral infection in primary cadaveric liver allograft versus primary living-donor allograft in 100 consecutive liver transplant recipients receiving tacrolimus.

Authors: Adel Bozorgzadeh; Ashok Jain; Charlotte Ryan; Daniel Ornt; Martin Zand; Parvez Mantry; Kerrie Lansing; Mark Orloff
Journal: Transplantation Date: 2004-04-15 Impact factor: 4.939

7. Hepatitis C recurrence is more severe after living donor compared to cadaveric liver transplantation.

Authors: Montserrat Garcia-Retortillo; Xavier Forns; Josep M Llovet; Miquel Navasa; Anna Feliu; Anna Massaguer; Miquel Bruguera; Josep Fuster; Juan Carlos Garcia-Valdecasas; Antoni Rimola
Journal: Hepatology Date: 2004-09 Impact factor: 17.425

8. Fulminant and fatal gas gangrene of the stomach in a healthy live liver donor.

Authors: Charles Miller; Sander Florman; Leona Kim-Schluger; Patrick Lento; Julia De La Garza; Josephine Wu; Boxun Xie; Wandi Zhang; Edward Bottone; David Zhang; Myron Schwartz
Journal: Liver Transpl Date: 2004-10 Impact factor: 5.799

9. Histologic recurrence of chronic hepatitis C virus in patients after living donor and deceased donor liver transplantation.

Authors: Mitchell L Shiffman; R Todd Stravitz; Melissa J Contos; A Scott Mills; Richard K Sterling; Velimir A Luketic; Arun J Sanyal; Adrian Cotterell; Daniel Maluf; Marc P Posner; Robert A Fisher
Journal: Liver Transpl Date: 2004-10 Impact factor: 5.799

10. Graft and patient survival after adult live donor liver transplantation compared to a matched cohort who received a deceased donor transplantation.

Authors: Paul J Thuluvath; Hwan Y Yoo
Journal: Liver Transpl Date: 2004-10 Impact factor: 5.799

5 in total

Living donor liver transplantation to patients with hepatitis C virus cirrhosis.

1. Is severe recurrent hepatitis C more common after adult living donor liver transplantation?

2. Diagnosis, management, and treatment of hepatitis C.

3. Successful liver transplantation from a living donor to her son.

4. Successful living-related partial liver transplantation to an adult patient.

5. The influence of HLA donor-recipient compatibility on the recurrence of HBV and HCV hepatitis after liver transplantation.

6. Impact of hepatitis C viral infection in primary cadaveric liver allograft versus primary living-donor allograft in 100 consecutive liver transplant recipients receiving tacrolimus.

7. Hepatitis C recurrence is more severe after living donor compared to cadaveric liver transplantation.

8. Fulminant and fatal gas gangrene of the stomach in a healthy live liver donor.

9. Histologic recurrence of chronic hepatitis C virus in patients after living donor and deceased donor liver transplantation.

10. Graft and patient survival after adult live donor liver transplantation compared to a matched cohort who received a deceased donor transplantation.

Review 1. Liver Transplantation: East versus West.

Review 2. Post-liver transplant hepatitis C virus recurrence: an unresolved thorny problem.

3. Liver transplantation and hepatitis C.

4. Living-donor liver transplantation and hepatitis C.

5. Computational models of liver fibrosis progression for hepatitis C virus chronic infection.